Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms (LUTS) Post Ureteroscopy for Stone Management

Trial Profile

Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms (LUTS) Post Ureteroscopy for Stone Management

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Aug 2012

At a glance

  • Drugs Solifenacin (Primary)
  • Indications Lower urinary tract symptoms; Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Aug 2012 Actual end date Jun 2012 added as reported by ClinicalTrials.gov.
    • 18 Jul 2012 New trial record
    • 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top